US Neurosurgical Holding (US Neurosurgical Holding) 3-Year Book Growth Rate : -47.40% (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is US Neurosurgical Holding 3-Year Book Growth Rate?

US Neurosurgical Holding's Book Value per Share for the quarter that ended in Dec. 2023 was $0.07.

During the past 12 months, US Neurosurgical Holding's average Book Value per Share Growth Rate was -56.30% per year. During the past 3 years, the average Book Value per Share Growth Rate was -47.40% per year. During the past 5 years, the average Book Value per Share Growth Rate was -28.60% per year. During the past 10 years, the average Book Value per Share Growth Rate was -5.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of US Neurosurgical Holding was 34.90% per year. The lowest was -47.40% per year. And the median was 2.70% per year.

Competitive Comparison of US Neurosurgical Holding's 3-Year Book Growth Rate

For the Medical Care Facilities subindustry, US Neurosurgical Holding's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

US Neurosurgical Holding's 3-Year Book Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, US Neurosurgical Holding's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where US Neurosurgical Holding's 3-Year Book Growth Rate falls into.

US Neurosurgical Holding 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

US Neurosurgical Holding (OTCPK:USNU) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

US Neurosurgical Holding 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of US Neurosurgical Holding's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

US Neurosurgical Holding (US Neurosurgical Holding) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » US Neurosurgical Holding Inc (OTCPK:USNU) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

2400 Research Boulevard, Suite 325, Rockville, MD, USA, 20850

Website

http://www.usneuro.com

US Neurosurgical Holding Inc operates as a holding company in United State. It is a medical services company that partners with hospitals and physicians to operate facilities utilizing artistic and inventive technologies in medical treatment and diagnosis. It is engaged in providing medical treatment and diagnosis services that include stereotactic radiosurgery centers, utilizing gamma knife technology, and holds interests in radiological treatment facilities. The company is focusing on establishing cancer centers using intensity-modulated radiation therapy. Its gamma knife is a stereotactic radiosurgical device used to treat brain tumors and other malformations of the brain without invasive surgery.

Executives

Lawrence William St	director	23 ASHLAND STREET, NEWBURYPORT MA 01950-1905
William F. Leimkuhler	director	43 SALEM STRAITS RD, DARIEN CT 06820
Merriman Charles H Iii	director
Alan Gold	director, 10 percent owner, officer: President & Chairman	2400 RESEARCH BLVD, SUITE 325, ROCKVILLE MD 20850
Stanley S Shuman	10 percent owner	C/O RIPPLEWOOD HOLDINGS LLC, ONE ROCKERFELLER PLAZA, NEW YORK NY 10020
Allen & Co Inc	10 percent owner	711 FIFTH AVENUE, NEW YORK NY 10022

US Neurosurgical Holding (US Neurosurgical Holding) Headlines

No Headlines